Patients with depression experience a decrease in 5-HT levels, an up-regulation in the 5-HT receptor, and functional decline of SERT resulting in reduced 5-HT re-uptake rate and inter-synaptic 5-HT concentration imbalance [35-37]. This evidence concerns the gene SLC6A4 and depressive symptom measurement.